New 
		York takes Teva, McKesson, others to trial over opioids
			
   
            
			Send a link to a friend  
 
			
		[June 29, 2021]  
		By Brendan Pierson 
		 
		NEW YORK (Reuters) - New York will take 
		Teva Pharmaceutical Industries and other companies, including the 
		nation's largest drug distributors, to trial on Tuesday, seeking to hold 
		them liable for fueling an opioid crisis that has caused nearly half a 
		million U.S. deaths over a decade. 
             | 
        
        
            | 
             
			
			 The trial in Central Islip, New York, will mark the first time 
			claims over the national opioid abuse and overdose epidemic go 
			before a jury. 
			 
			It will pit state Attorney General Letitia James and Suffolk and 
			Nassau Counties against drugmakers Teva, Endo International and 
			Abbvie Inc, as well as drug distributors AmerisourceBergen Corp, 
			Cardinal Health Inc and McKesson Corp. 
			 
			Another defendant in the case, drugmaker Johnson & Johnson, 
			announced on Saturday it would pay $263 million to settle and avoid 
			the trial. 
			 
			New York and the counties claim that drug companies deceptively 
			promoted opioids as safe, and that distributors ignored red flags 
			that they were being diverted to illegal channels. 
			
			  
			More than 3,000 lawsuits have been filed in the United States 
			against drugmakers, distributors and pharmacies over the opioid 
			epidemic, mostly by city, county and tribal governments. 
			 
			Non-jury trials are already underway in cases brought against the 
			four drugmakers by several counties in California, and against the 
			three distributors by a city and county in West Virginia. 
			
            [to top of second column]  | 
            
             
			
			    The New York counties had also 
								sued pharmacy operators Walmart Inc, Rite Aid 
								Corp and CVS Health Corp, but they were dropped 
								from the trial during jury selection earlier 
								this month. CVS said it had settled, without 
								disclosing terms, while Walmart and Rite Aid 
								declined to comment. 
								 
								J&J and the three distributors last year 
								proposed paying a combined $26 billion to settle 
								all opioid claims against them nationwide, but 
								the deal has not been finalized. 
								 
								The U.S. Centers for Disease Control and 
								Prevention has said nearly 500,000 people died 
								from opioid overdoses from 1999 to 2019. 
								 
								(Reporting By Brendan Pierson in New York; 
								Editing by Noeleen Walder and Bill Berkrot) 
			[© 2021 Thomson Reuters. All rights 
				reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content    |